Form 4: Boston Scientific Director Sells Shares Under Pre-Planned Arrangement

Boston Scientific Director Edward J. Ludwig sold 4,000 shares of common stock for over $106 per share in a pre-planned transaction.

Summary

• Director Edward J. Ludwig disposed of 4,000 shares of Boston Scientific Corp. common stock.
• The transaction occurred on July 25, 2025.
• Shares were sold at a price of $106.0301 per share.
• Following the sale, Edward J. Ludwig beneficially owns 18,479 shares of common stock.
• The transaction was conducted pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale.

Sentiment

Score: 5

Explanation: The sale of shares by a director, while reducing insider ownership, was conducted under a Rule 10b5-1 plan, suggesting a pre-arranged transaction rather than a reaction to new information, thus indicating a neutral sentiment.

Negatives

• Director Edward J. Ludwig reduced his direct ownership in Boston Scientific Corp. by selling 4,000 shares.

Future Outlook

NA

Industry Context

NA

Key Dates

Recommendation

The sale of 4,000 shares by a director, while reducing insider ownership, was conducted under a Rule 10b5-1 plan, indicating a pre-arranged transaction. This type of transaction is generally not considered a strong signal for future stock performance and does not warrant a change from a 'hold' recommendation for a company of Boston Scientific's size and market capitalization.

Keywords

Boston Scientific, BSX, insider trading, Form 4, stock sale, director, Edward J. Ludwig, common stock, Rule 10b5-1